Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Physician Pay Reform Bill Could Be Sucked Into Obamacare Politics

This article was originally published in The Gray Sheet

Executive Summary

Multiple payment offsets for comprehensive Medicare physician payment reform are under discussion, but House Republicans are apparently considering employing repeal of the individual mandate for that purpose, which could undermine the bill in the Senate.

You may also be interested in...



House Physician Pay Bill Cheaper Than Senate Version, But Lacks Extenders

A pair of late-January estimates by the Congressional Budget Office of SGR reform bills prices the Senate Finance committee’s SGR bill at $150.4 billion and the House Ways and Means Committee’s version at $121 billion, but the House bill lacks important Medicare and Medicaid extenders due to expire soon.

FDA Budget, Physician Payments On Tap For Congress In The New Year

Congress is on a tight schedule to approve federal appropriations bills for FDA and other agencies. It may also take up comprehensive physician payment reform bills that passed out of committees late in 2013; legislation that could have important implications for the device space. Also to look out for: a changing of the guard in the powerful Senate Finance Committee.

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT032815

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel